EIBIR Winter School on Interdisciplinary Biomedical Imaging

17-22 January 2010, Viladrau, Spain.
The main objective of the EIBIR Winter School is to support the interdisciplinary training of technical and clinical PhD students working in the broad area of biomedical imaging. In this first EIBIR Winter School on Interdisciplinary Biomedical Imaging, two key clinical disease areas will be addressed which altogether represent the two leading causes of death worldwide: cardiovascular and oncologic diseases. Each topic will be covered from the perspective of novel methods for biomedical image acquisition, analysis and interpretation as well as from the perspective of computational modeling and interventional planning, where appropriate. The themes will be explored based on the key driving clinical questions as well as from an understanding of the underlying disease mechanisms or pathophysiology.

The faculty will include lecturers with a clinical, biomedical and technical background, from both academia and industry. Reading groups, poster sessions and social activities will be offered.

Target Group
Second- and third-year students pursuing their graduate studies within PhD programs of biomedical engineering, computer science, electrical engineering, physics, medical physics, and medicine. Participants should have a basic understanding of biomedical imaging in terms of acquisition and image analysis and interpretation. Possibility to earn CME credits.

Location
Viladrau/Spain, about 70km from Barcelona, located within the Montseny Natural Park

Application
Via email to This email address is being protected from spambots. You need JavaScript enabled to view it., until October 22nd, 2009 including:

  • Curriculum Vitae including contact details of two referees and current main supervisor
  • Letter of intention
Number of participants admitted: 45 PhD students;

Notification of selected candidates: Before November 15th 2009

Participation fees
EUR 645,- (twin room)
EUR 795,- (single room)
Including attendance of the course, full board accommodation, bus from Barcelona to Viladrau and back, all social activities. Payment of registration fees before December 1st, 2009.

For further information, please visit:
http://www.eibir.org

About EIBIR
The European Institute for Biomedical Imaging Research (EIBIR) is a non-profit limited liability company that was founded in 2006 by the European Society of Radiology (ESR), dedicated to the co-ordination of research.

EIBIR has the aim of co-ordinating and supporting the development of biomedical imaging technologies and the dissemination of knowledge with the ultimate goal of improving diagnosis, treatment and prevention of disease.

The platform supports networking activities in research and is key to spreading good practice, promoting common initiatives and interoperability in the field of biomedical imaging research.

Most Popular Now

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...